share_log

2月7日回购集合 | 药明生物、汇丰控股等纷纷回购,其中药明生物耗资2.34亿港元

Repurchase Collection on February 7 | Pharmaceutical Biotech, HSBC Holdings, etc. bought back one after another. Of these, Yao Ming Biotech cost HK$234 million

Futu News ·  Feb 8 09:00

According to HKEx's February 8 disclosure documents,$WUXI BIO (02269.HK)$,$HSBC HOLDINGS (00005.HK)$Wait for the shares to be repurchased.

$WUXI BIO (02269.HK)$12,147,500 common shares were repurchased on February 7, involving an amount of HK$234 million. The repurchase price per share ranged from HK$19.7 to HK$18.9.

The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 82.417 million shares, accounting for 1.94% of the number of shares issued when the ordinary resolution was passed.

$HSBC HOLDINGS (00005.HK)$2.498 million common shares were repurchased on February 6, involving an amount of HK$154 million. The repurchase price for each share ranged from HK$61.85 to HK$60.95.

$HAIER SMARTHOME (06690.HK)$On February 7, 2,421,400 A-shares were repurchased, involving an amount of $57.3973 million. The repurchase price per share ranged from $23.81 to $23.61.

$XIAOMI-W (01810.HK)$On February 7, 4 million common shares were repurchased, involving an amount of HK$59.473 million, with a repurchase price of HK$12.78 to HK$12.68 per share.

The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 244 million shares, accounting for 0.97% of the number of shares issued when the ordinary resolution was passed.

$KINGDEE INT'L (00268.HK)$On February 7, 3,077 million common shares were repurchased, involving an amount of HK$24.19,500. The repurchase price for each share ranged from HK$7.91 to HK$7.74.

The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 36.795 million shares, accounting for 1.06% of the number of shares issued when the ordinary resolution was passed.

See the chart below for details on share repurchases of listed companies:

AutoNews_HKSRPT_20240208.png

What is a stock buyback?

Stock repurchase refers to the act of a listed company using cash or the like to repurchase a certain amount of shares issued by the company from the stock market. The company may cancel the repurchased shares after the stock repurchase is completed. This will reduce the number of stocks that are out of circulation by enterprises, thereby achieving positive effects such as market value management, equity incentives, and stabilizing stock prices.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment